2.5. MDM2 binding assay

SK Stephen H. Kasper
SO Stephanie Otten
BS Brian Squadroni
CO Cionna Orr‐Terry
YK Yi Kuang
LM Lily Mussallem
LG Lan Ge
LY Lin Yan
SK Srinivasaraghavan Kannan
CV Chandra S. Verma
CB Christopher J. Brown
CJ Charles W. Johannes
DL David P. Lane
AC Arun Chandramohan
AP Anthony W. Partridge
LR Lee R. Roberts
HJ Hubert Josien
AT Alex G. Therien
EH Erik C. Hett
BH Bonnie J. Howell
AP Andrea Peier
XA Xi Ai
JC Jason Cassaday
ask Ask a question
Favorite

MDM2 protein generation and binding studies were performed as described. 17 Briefly, binding was performed using MDM2 (1–125) protein titrated against 50 nM carboxyfluorescein (FAM)—labeled 12/1 peptide13 (FAM‐RFMDYWEGL‐NH2). The apparent K D value of FAM‐labeled 12/1peptide was determined to be 13.0 nM and subsequently used to determine the apparent K D values of the respective competing ligands in competition assays in fluorescence anisotropy experiments. Titrations were carried out with the concentration of MDM2 held constant at 250 nM and the labeled peptide at 50 nM. The competing molecules were then titrated against the complex of the FAM‐labeled peptide and protein. Curve‐fitting was carried out using Prism 4.0 (GraphPad) to determine K D values. Readings were carried out with an Envision Multilabel Reader (PerkinElmer). Experiments were carried out in PBS (2.7 mM KCl, 137 mM NaCl, 10 mM Na2HPO4, and 2 mM KH2PO4 [pH 7.4]) and 0.1% Tween 20 buffer. All titrations were carried out in triplicate.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A